These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20023432)

  • 1. Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery.
    Yamada R; Kostova MB; Anchoori RK; Xu S; Neamati N; Khan SR
    Cancer Biol Ther; 2010 Feb; 9(3):192-203. PubMed ID: 20023432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promise of paclitaxel-peptide conjugates for MMP-2-targeted drug delivery.
    Huang Y; Shi J; He Q; Sheikh MS
    Cancer Biol Ther; 2010 Feb; 9(3):204-5. PubMed ID: 20118656
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
    Chen X; Plasencia C; Hou Y; Neamati N
    J Med Chem; 2005 Feb; 48(4):1098-106. PubMed ID: 15715477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies.
    Wang X; Chen Q; Zhang X; Ren X; Zhang X; Meng L; Liang H; Sha X; Fang X
    Int J Nanomedicine; 2018; 13():4641-4659. PubMed ID: 30147314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
    J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
    Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X
    Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Transdermal Drug Delivery by Transfersome-Embedded Oligopeptide Hydrogel for Topical Chemotherapy of Melanoma.
    Jiang T; Wang T; Li T; Ma Y; Shen S; He B; Mo R
    ACS Nano; 2018 Oct; 12(10):9693-9701. PubMed ID: 30183253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
    Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
    Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatible AIEgen/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer.
    Wu J; Wang Q; Dong X; Xu M; Yang J; Yi X; Chen B; Dong X; Wang Y; Lou X; Xia F; Wang S; Dai J
    Theranostics; 2021; 11(8):3710-3724. PubMed ID: 33664857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP).
    Vanhoefer U; Cao S; Harstrick A; Seeber S; Rustum YM
    Ann Oncol; 1997 Dec; 8(12):1221-8. PubMed ID: 9496387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer.
    Bu H; He X; Zhang Z; Yin Q; Yu H; Li Y
    Int J Pharm; 2014 Aug; 471(1-2):206-13. PubMed ID: 24866272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
    Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
    J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of paclitaxel and vorinostat co-prodrugs for overcoming drug resistance in cancer therapy in vitro.
    Liu S; Zhang K; Zhu Q; Shen Q; Zhang Q; Yu J; Chen Y; Lu W
    Bioorg Med Chem; 2019 Apr; 27(7):1405-1413. PubMed ID: 30819618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
    Jin X; Mo R; Ding Y; Zheng W; Zhang C
    Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release strategy of paclitaxel by conjugating to matrix metalloproteinases-2 sensitive peptide.
    Huang C; Yi X; Kong D; Chen L; Min G
    Oncotarget; 2016 Aug; 7(32):52230-52238. PubMed ID: 27447567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced absorption, and efficacy of oral self-assembled paclitaxel nanocochleates in multi-drug resistant colon cancer.
    Shanmugam T; Joshi N; Ahamad N; Deshmukh A; Banerjee R
    Int J Pharm; 2020 Aug; 586():119482. PubMed ID: 32492505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
    Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel.
    Pei X; Luo F; Zhang J; Chen W; Jiang C; Liu J
    Sci Rep; 2017 Apr; 7(1):975. PubMed ID: 28428562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.